|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/06 | |
| A61K 38/07 | |||
| A61P 9/00 | |||
| A61P 9/10 |
| (11) | Number of the document | 2908839 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13849406.7 |
| Date of filing the European patent application | 2013-10-22 | |
| (97) | Date of publication of the European application | 2015-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/066228 |
| Date | 2013-10-22 |
| (87) | Number | WO 2014/066419 |
| Date | 2014-05-01 |
| (30) | Number | Date | Country code |
| 201261716867 P | 2012-10-22 | US | |
| 201361822752 P | 2013-05-13 | US | |
| 201361839743 P | 2013-06-26 | US | |
| 201361839750 P | 2013-06-26 | US |
| (72) |
WILSON, D. Travis, US
SABBAH, Hani N., US
|
| (73) |
Stealth Peptides International, Inc.,
2nd Floor Le Prince de Galles 3-5 Avenue des Citronniers, 98000 Monte-Carlo,
MC
Henry Ford Health Systems, 2799 West Grand Boulevard, Detroit, MI 48202, US |
| (54) | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH |
| METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH |